Kannaway, LLC is a pioneer name in the industry that offers natural CBD hemp botanical items. It is a subsidiary of Medical Marijuana Inc (OTCMKTS:MJNA). Recently, it released sales revenue figure revealing a growth of 42% in new sales revenue. The recorded sale was achieved in the quarter ended February 28, 2015. In the quarter itself, Medical Marijuana bought Kannaway. The news of the acquisition received a warm response from shareholders and provided a much needed cushion to the declining stock. In the same period, the subsidiary more than doubled its brand ambassadors.
Medical Marijuana significantly benefitted from the recent acquisition of Kannaway as the subsidiary company recorded strong sales. Also, it brought additional recognition for the company as it was included in the list of best start-up firms for 2014. The legal advisor of Kannaway also got honored by the directsellinglive.com. He was also included in the list of best advocates for the year 2014.
Jeff Rogers who is the Chief Executive of Kannaway expressed that it is a great honor to be acknowledged by TAMM. The company was included in the list of best new start-up firms in the industry. It is on a path to educate and direct customers on the right facts of hemp history. The recognition in prestigious category reflects the passion and commitment of Medical Marijuana towards the mission. It highlights the key message of the hemp revitalization across all cities in the U.S. The time is changing and Kannaway is playing a vital role in repositioning hemp consumer offerings in the industry.
The growing sector
Medical Marijuana recently selected CEO Stuart Titus highlighted the “Kannaway Nation” focusing on his professional background. He wants to record a strong progress in the rising industrial hemp industry and can be achieved through portfolio units including Kannaway. In last trading session, MJNA stock price surged 0.55% to close at $0.0910.